Table 2 High-energy blunt type B and C pelvic ring injury patients’ characteristics (2014–2020)
Period | ISS (median, IQR1-3) | HD instability rate (%) and PRBC/24 h [median (IQR1-3)] | Death rate (%) and timing [in days: median (IQR1-3)] | ICU rate (%) and LOS [in days: median (IQR1-3)] | Hospital LOS [in days: median (IQR1-3)] | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | Full year | Mar 16–Jun 19 | |
2014 | 26 (18.5–29) | 31.5 (24–38) | 14%; 5 (4–8) | 25%; 20.5 (10.8–30.2) | 14%; 11 (6–16) | 25%; 1 (1–1) | 50%; 12 (6.5–15.5) | 25%; 22 (22–22) | 16.5 (9–20.8) | 10 (4.8–24) |
2015 | 20.5 (16.8–27.2) | 18.5 (15.2–22) | 19%; 3 (2–4.8) | 0%; - | 0%; - | 0%; - | 50%; 7 (3.5–11.5) | 0%; - | 18.5 (11.8–29.5) | 9 (7–11.5) |
2016 | 29 (22–38) | 24 (20–32.5) | 24%; 5 (3.5–7.5) | 29%; 4 (3.5–6.5) | 24%; 17 (11.8–27) | 29%; 26.5 (14.2–38.8) | 71%; 6.5 (2–9.8) | 71%; 2 (2–5) | 15 (7–27) | 20 (9–39) |
2017 | 22 (17.2–40.2) | 30.5 (21.5–35.8) | 35%; 7 (4–10) | 50%; 8.5 (6.2–10) | 12%; 1 (1–26.5) | 13%; 1 (1–1) | 42%; 11 (8–25.5) | 63%; 16 (7.8–24.5) | 19 (11–52) | 27 (8.5–65) |
2018 | 29 (19.8–34) | 24 (19–29) | 21%; 2 (2–2) | 20%; 2 (2–2) | 14%; 4.5 (2.8–6.2) | 0%; - | 57%; 10.5 (3.5–17.5) | 60%; 11 (11–24) | 19 (13–23.8) | 24 (21–75) |
2019 | 22 (13–27) | 21 (14–26.2) | 35%; 12.5 (11.2–13.8) | 20%; 15 (15–15) | 12%; 5 (3–7) | 10%; 9 (9–9) | 35%; 1.5 (1–8.8) | 50%; 1 (1–2) | 35 (26–57) | 32 (18.5–43.8) |
2020 | 22.5 (18.2–32.8) | 27 (11.8–39.2) | 29%; 1.5 (1–5.2) | 33%; 1.5 (1.2–1.8) | 0%; - | 0%; - | 29%; 7 (6–13) | 50%; 7 (5–7) | 13 (9–19.2) | 14 (10.2–14) |